236 related articles for article (PubMed ID: 25194662)
21. Mesenchymal stem cells ameliorate experimental peritoneal fibrosis by suppressing inflammation and inhibiting TGF-β1 signaling.
Ueno T; Nakashima A; Doi S; Kawamoto T; Honda K; Yokoyama Y; Doi T; Higashi Y; Yorioka N; Kato Y; Kohno N; Masaki T
Kidney Int; 2013 Aug; 84(2):297-307. PubMed ID: 23486522
[TBL] [Abstract][Full Text] [Related]
22. Ex vivo analysis of dialysis effluent-derived mesothelial cells as an approach to unveiling the mechanism of peritoneal membrane failure.
López-Cabrera M; Aguilera A; Aroeira LS; Ramírez-Huesca M; Pérez-Lozano ML; Jiménez-Heffernan JA; Bajo MA; del Peso G; Sánchez-Tomero JA; Selgas R
Perit Dial Int; 2006; 26(1):26-34. PubMed ID: 16538870
[TBL] [Abstract][Full Text] [Related]
23. BMP-7 blocks mesenchymal conversion of mesothelial cells and prevents peritoneal damage induced by dialysis fluid exposure.
Loureiro J; Schilte M; Aguilera A; Albar-Vizcaíno P; Ramírez-Huesca M; Pérez-Lozano ML; González-Mateo G; Aroeira LS; Selgas R; Mendoza L; Ortiz A; Ruíz-Ortega M; van den Born J; Beelen RH; López-Cabrera M
Nephrol Dial Transplant; 2010 Apr; 25(4):1098-108. PubMed ID: 20067910
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of Rho-kinase alleviates peritoneal fibrosis and angiogenesis in a rat model of peritoneal dialysis.
Peng W; Zhou Q; Ao X; Tang R; Xiao Z
Ren Fail; 2013 Aug; 35(7):958-66. PubMed ID: 23859538
[TBL] [Abstract][Full Text] [Related]
25. The dipeptide alanyl-glutamine ameliorates peritoneal fibrosis and attenuates IL-17 dependent pathways during peritoneal dialysis.
Ferrantelli E; Liappas G; Vila Cuenca M; Keuning ED; Foster TL; Vervloet MG; Lopéz-Cabrera M; Beelen RH
Kidney Int; 2016 Mar; 89(3):625-35. PubMed ID: 26880457
[TBL] [Abstract][Full Text] [Related]
26. Peritoneal fibrosis and high transport are induced in mildly pre-injured peritoneum by 3,4-dideoxyglucosone-3-ene in mice.
Yokoi H; Kasahara M; Mori K; Kuwabara T; Toda N; Yamada R; Namoto S; Yamamoto T; Seki N; Souma N; Yamaguchi T; Sugawara A; Mukoyama M; Nakao K
Perit Dial Int; 2013; 33(2):143-54. PubMed ID: 23123666
[TBL] [Abstract][Full Text] [Related]
27. Mesenchymal conversion of mesothelial cells as a mechanism responsible for high solute transport rate in peritoneal dialysis: role of vascular endothelial growth factor.
Aroeira LS; Aguilera A; Selgas R; Ramírez-Huesca M; Pérez-Lozano ML; Cirugeda A; Bajo MA; del Peso G; Sánchez-Tomero JA; Jiménez-Heffernan JA; López-Cabrera M
Am J Kidney Dis; 2005 Nov; 46(5):938-48. PubMed ID: 16253736
[TBL] [Abstract][Full Text] [Related]
28. Tamoxifen ameliorates peritoneal membrane damage by blocking mesothelial to mesenchymal transition in peritoneal dialysis.
Loureiro J; Sandoval P; del Peso G; Gónzalez-Mateo G; Fernández-Millara V; Santamaria B; Bajo MA; Sánchez-Tomero JA; Guerra-Azcona G; Selgas R; López-Cabrera M; Aguilera AI
PLoS One; 2013; 8(4):e61165. PubMed ID: 23637793
[TBL] [Abstract][Full Text] [Related]
29. Curcumin ameliorates peritoneal fibrosis via inhibition of transforming growth factor-activated kinase 1 (TAK1) pathway in a rat model of peritoneal dialysis.
Zhao JL; Zhang T; Shao X; Zhu JJ; Guo MZ
BMC Complement Altern Med; 2019 Oct; 19(1):280. PubMed ID: 31647008
[TBL] [Abstract][Full Text] [Related]
30. Prolonged peritoneal gene expression using a helper-dependent adenovirus.
Liu L; Shi CX; Ghayur A; Zhang C; Su JY; Hoff CM; Margetts PJ
Perit Dial Int; 2009; 29(5):508-16. PubMed ID: 19776043
[TBL] [Abstract][Full Text] [Related]
31. Gremlin-1: An endogenous BMP antagonist induces epithelial-mesenchymal transition and interferes with redifferentiation in fetal RPE cells with repeated wounds.
Li D; Yuan D; Shen H; Mao X; Yuan S; Liu Q
Mol Vis; 2019; 25():625-635. PubMed ID: 31700227
[TBL] [Abstract][Full Text] [Related]
32. The role of WNT5A and Ror2 in peritoneal membrane injury.
Padwal M; Liu L; Margetts PJ
J Cell Mol Med; 2020 Mar; 24(6):3481-3491. PubMed ID: 32052562
[TBL] [Abstract][Full Text] [Related]
33. Caffeic acid phenethyl ester restores mitochondrial homeostasis against peritoneal fibrosis induced by peritoneal dialysis through the AMPK/SIRT1 pathway.
Lu Y; Gao L; Zhang W; Zeng Y; Hu J; Song K
Ren Fail; 2024 Dec; 46(1):2350235. PubMed ID: 38721924
[TBL] [Abstract][Full Text] [Related]
34. Parthenolide, an NF-κB inhibitor, alleviates peritoneal fibrosis by suppressing the TGF-β/Smad pathway.
Zhang Y; Huang Q; Chen Y; Peng X; Wang Y; Li S; Wu J; Luo C; Gong W; Yin B; Xiao J; Zhou W; Peng F; Long H
Int Immunopharmacol; 2020 Jan; 78():106064. PubMed ID: 31838448
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of Transglutaminase 2 Reduces Peritoneal Injury in a Chlorhexidine-Induced Peritoneal Fibrosis Model.
Kunoki S; Tatsukawa H; Sakai Y; Kinashi H; Kariya T; Suzuki Y; Mizuno M; Yamaguchi M; Sasakura H; Ikeno M; Takeuchi K; Ishimoto T; Hitomi K; Ito Y
Lab Invest; 2023 Apr; 103(4):100050. PubMed ID: 36870292
[TBL] [Abstract][Full Text] [Related]
36. Increased expression of epimorphin in a peritoneal fibrosis mouse model.
Yamada M; Hirai Y; Inoue D; Komatsu S; Uchida T; Kojima T; Tomiyasu T; Yoshikawa N; Oda T
Perit Dial Int; 2022 Sep; 42(5):522-529. PubMed ID: 34641723
[TBL] [Abstract][Full Text] [Related]
37. The Therapeutic Potential of Human Umbilical Mesenchymal Stem Cells From Wharton's Jelly in the Treatment of Rat Peritoneal Dialysis-Induced Fibrosis.
Fan YP; Hsia CC; Tseng KW; Liao CK; Fu TW; Ko TL; Chiu MM; Shih YH; Huang PY; Chiang YC; Yang CC; Fu YS
Stem Cells Transl Med; 2016 Feb; 5(2):235-47. PubMed ID: 26718649
[TBL] [Abstract][Full Text] [Related]
38. Nebivolol, a β1-adrenergic blocker, protects from peritoneal membrane damage induced during peritoneal dialysis.
Liappas G; González-Mateo G; Aguirre AR; Abensur H; Albar-Vizcaino P; Parra EG; Sandoval P; Ramírez LG; Del Peso G; Acedo JM; Bajo MA; Selgas R; Sánchez Tomero JA; López-Cabrera M; Aguilera A
Oncotarget; 2016 May; 7(21):30133-46. PubMed ID: 27102153
[TBL] [Abstract][Full Text] [Related]
39. Pyrrole-imidazole polyamide targeting transforming growth factor β1 ameliorates encapsulating peritoneal sclerosis.
Serie K; Fukuda N; Nakai S; Matsuda H; Maruyama T; Murayama Y; Omata S
Perit Dial Int; 2012; 32(4):462-72. PubMed ID: 22215658
[TBL] [Abstract][Full Text] [Related]
40. Peritoneal morphological and functional changes associated with platelet-derived growth factor B.
Cina D; Patel P; Bethune JC; Thoma J; Rodriguez-Lecompte JC; Hoff CM; Liu L; Margetts PJ
Nephrol Dial Transplant; 2009 Feb; 24(2):448-57. PubMed ID: 18775895
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
